Cord blood boost: new treatment shows promise for tough leukemia cases
NCT ID NCT04103879
First seen Apr 02, 2026 · Last updated Apr 26, 2026 · Updated 3 times
Summary
This study tested a method to grow more stem cells from a single cord blood unit before transplant in 30 people with high-risk leukemia or myelodysplasia. The goal was to help the new cells take hold faster and reduce serious side effects. Early results suggest this approach may improve survival and lower complications, but lifelong monitoring is still needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORD BLOOD TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Erasmus Medical Center
Rotterdam, Gelderland, 3015, Netherlands
-
Fred Hutchinson / University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
-
University of Colorado School of Medicine. Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.